The role of the long non‐coding RNA HOXA11‐AS in promoting proliferation and metastasis of malignant tumors

Citations Over TimeTop 18% of 2018 papers

Abstract

Long non-coding RNA (lncRNA) is one of the focuses and hotspots of biological research in recent years. At the same time, tumors have become the main disease that endangers human health. In recent years, a large number of researchers have explored the relationship between lncRNA and tumors. HOXA11-AS is one of these lncRNAs. The long non-coding RNA HOXA11 antisense RNA (HOXA11-AS) is a novel lncRNA recently discovered. It is found in a variety of tumors such as ovarian cancer, glioma, and gastric cancer (GC) and so on, and is defined as an oncogene. It promotes tumor proliferation and metastasis by interacting with proteins such as miRNA and EZH2. In this paper, we review the mechanism of interaction between HOXA11-AS and various tumors in recent years, and believe that it can be a potential tumor marker and therapeutic target in the future prevention and treatment of tumors.

Related Papers

• → Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway(2017)77 cited
• → Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancer(2017)38 cited
• → Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma(2021)38 cited
• → Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR‑206(2018)36 cited
• → Long non‑coding RNA XIST predicts poor prognosis and promotes malignant phenotypes in osteosarcoma(2018)20 cited